Literature DB >> 16933225

Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: chasing windmills?

Gary L Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16933225     DOI： 10.1002/lt.20889

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  6 in total

1.  Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.

Authors:  R T Chung; F D Gordon; M P Curry; T D Schiano; S Emre; K Corey; J F Markmann; M Hertl; J J Pomposelli; E A Pomfret; S Florman; M Schilsky; T J Broering; R W Finberg; G Szabo; P D Zamore; U Khettry; G J Babcock; D M Ambrosino; B Leav; M Leney; H L Smith; D C Molrine
Journal:  Am J Transplant       Date:  2013-01-28       Impact factor: 8.086

Review 2.  Development of hepatitis C virus vaccines: challenges and progress.

Authors:  Françoise Stoll-Keller; Heidi Barth; Samira Fafi-Kremer; Mirjam B Zeisel; Thomas F Baumert
Journal:  Expert Rev Vaccines       Date:  2009-03       Impact factor: 5.217

3.  Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90.

Authors:  Terence N Bukong; Fatemeh Momen-Heravi; Karen Kodys; Shashi Bala; Gyongyi Szabo
Journal:  PLoS Pathog       Date:  2014-10-02       Impact factor: 6.823

4.  Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.

Authors:  Pei Zhang; Lilin Zhong; Evi Budo Struble; Hisayoshi Watanabe; Alla Kachko; Kathleen Mihalik; Maria Luisa Virata; Harvey J Alter; Stephen Feinstone; Marian Major
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

5.  Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.

Authors:  Trevor J Morin; Teresa J Broering; Brett A Leav; Barbra M Blair; Kirk J Rowley; Elisabeth N Boucher; Yang Wang; Peter S Cheslock; Michael Knauber; David B Olsen; Steve W Ludmerer; Gyongyi Szabo; Robert W Finberg; Robert H Purcell; Robert E Lanford; Donna M Ambrosino; Deborah C Molrine; Gregory J Babcock
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

6.  Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma.

Authors:  Pei Zhang; Charles G Wu; Kathleen Mihalik; Maria Luisa Virata; Mei-Ying W Yu; Harvey J Alter; Stephen M Feinstone
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.